Also called HBME-1 Marker of mesothelial cells, named after laboratory of Dr. H ector B attifora and ME sothelioma Also positive in various thyroid carcinomas Microscopic (histologic) images Contributed by Andrey Bychkov, M.D., Ph.D. Tumor interface Striking membranous staining Strong membranous HBME-1 immunoreactivity Strong HBME-1 WebAug 4, 2024 · The statistical analysis of the results of the cytoplasmic immunostaining revealed that the level expression of the four markers (gal-1, gal-3, CK19 and HBME-1) …
Lights on HBME-1: the elusive biomarker in thyroid cancer
WebJun 16, 2013 · Suggested Immunohistochemistry Tissue Controls Advertisements Here is our comprehensive IHC tissue control list. It is also posted as one file under the histology section. There are 16 pages of our version, but I will try to condense it here for you. These controls are all human tissues. WebMar 1, 2001 · Positive HBME-1 immunostaining is in support of the diagnosis of the follicular variant of papillary carcinoma and highlights micropapillary carcinomas. HBME … cliff house arizona
Immunohistochemical markers in the diagnosis of papillary
WebApr 22, 2024 · In the present review, the different clinical applications of HBME-1 are analysed, with main emphasis on its role in thyroid pathology with overview on less … WebImmunocytochemical panel for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions A panel of CEA, CK19 and HBME-1 monoclonal antibodies proved to be suitable for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions. WebFeb 22, 2014 · Triple Immunostaining. Body fluids with benign mesothelial cells and macrophages were used as cytologic controls (mesothelial cells are positive for HBME-1 … board icpc